Membrane-Mediated Cooperative Interactions of CD47 and SIRPα

被引:3
作者
Li, Long [1 ,2 ,3 ]
Gui, Chen [1 ]
Hu, Jinglei [1 ]
Rozycki, Bartosz [4 ]
机构
[1] Nanjing Univ, Kuang Yaming Honors Sch, Nanjing 210023, Peoples R China
[2] Chinese Acad Sci, State Key Lab Nonlinear Mech, Beijing 100190, Peoples R China
[3] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construction & Mechanobiol, Beijing 100190, Peoples R China
[4] Polish Acad Sci, Inst Phys, Aleja Lotnikow 32-46, PL-02668 Warsaw, Poland
基金
中国国家自然科学基金;
关键词
membrane adhesion; biomimetics; computer simulations; CD47; SIRP alpha; RECEPTOR-LIGAND BINDING; ANCHORED RECEPTORS; AGGREGATION; ADHESION; PROTEINS; ENHANCE;
D O I
10.3390/membranes13110871
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specific binding of the ubiquitous 'marker of self' protein CD47 to the SIRP alpha protein anchored in the macrophage plasma membrane results in the inhibition of the engulfment of 'self' cells by macrophages and thus constitutes a key checkpoint of our innate immune system. Consequently, the CD47-SIRP alpha protein complex has been recognized as a potential therapeutic target in cancer and inflammation. Here, we introduce a lattice-based mesoscale model for the biomimetic system studied recently in fluorescence microscopy experiments where GFP-tagged CD47 proteins on giant plasma membrane vesicles bind to SIRP alpha proteins immobilized on a surface. Computer simulations of the lattice-based mesoscale model allow us to study the biomimetic system on multiple length scales, ranging from single nanometers to several micrometers and simultaneously keep track of single CD47-SIRP alpha binding and unbinding events. Our simulations not only reproduce data from the fluorescence microscopy experiments but also are consistent with results of several other experiments, which validates our numerical approach. In addition, our simulations yield quantitative predictions on the magnitude and range of effective, membrane-mediated attraction between CD47-SIRP alpha complexes. Such detailed information on CD47-SIRP alpha interactions cannot be obtained currently from experiments alone. Our simulation results thus extend the present understanding of cooperative effects in CD47-SIRP alpha interactions and may have an influence on the advancement of new cancer treatments.
引用
收藏
页数:13
相关论文
共 50 条
[31]   Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment [J].
Zhang, Liang ;
Huang, He .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (06) :658-667
[32]   Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer [J].
Giatromanolaki, Alexandra ;
Mitrakas, Achilleas ;
Anestopoulos, Ioannis ;
Kontosis, Andreas ;
Koukourakis, Ioannis M. ;
Pappa, Aglaia ;
Panayiotidis, Mihalis I. ;
Koukourakis, Michael I. .
CANCERS, 2022, 14 (07)
[33]   The macrophage checkpoint CD47: SIRPα for recognition of 'self' cells: from clinical trials of blocking antibodies to mechanobiological fundamentals [J].
Andrechak, Jason C. ;
Dooling, Lawrence J. ;
Discher, Dennis E. .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2019, 374 (1779)
[34]   Selective control of SIRP-α-positive airway dendritic cell trafficking through CD47 is critical for the development of TH2-mediated allergic inflammation [J].
Raymond, Marianne ;
Rubio, Manuel ;
Fortin, Genevieve ;
Shalaby, Karim Hamdy ;
Hammad, Hamida ;
Lambrecht, Bart N. ;
Sarfati, Marika .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (06) :1333-1342
[35]   The Effective Field Theory approach towards membrane-mediated interactions between particles [J].
Yolcu, Cem ;
Haussman, Robert C. ;
Deserno, Markus .
ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2014, 208 :89-109
[36]   Membrane-mediated interactions between disk-like inclusions adsorbed on vesicles [J].
Alizadeh-Haghighi, Elnaz ;
Karaei Shiraz, Arash ;
Bahrami, Amir H. .
FRONTIERS IN PHYSICS, 2022, 10
[37]   Self inhibition of phagocytosis: The affinity of 'marker of self' CD47 for SIRPα dictates potency of inhibition but only at low expression levels [J].
Tsai, Richard K. ;
Rodriguez, Pia L. ;
Discher, Dennis E. .
BLOOD CELLS MOLECULES AND DISEASES, 2010, 45 (01) :67-74
[38]   CD47 as a promising therapeutic target in oncology [J].
Zhao, Hai ;
Song, Shuangshuang ;
Ma, Junwei ;
Yan, Zhiyong ;
Xie, Hongwei ;
Feng, Ying ;
Che, Shusheng .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[39]   Deciphering the role of CD47 in cancer immunotherapy [J].
Liu, Yu'e ;
Weng, Linjun ;
Wang, Yanjin ;
Zhang, Jin ;
Wu, Qi ;
Zhao, Pengcheng ;
Shi, Yufeng ;
Wang, Ping ;
Fang, Lan .
JOURNAL OF ADVANCED RESEARCH, 2024, 63 :129-158
[40]   Role of CD47 in erythroid cells and in autoimmunity [J].
Oldenborg, PA .
LEUKEMIA & LYMPHOMA, 2004, 45 (07) :1319-1327